Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

601
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
601
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

333
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
333
Pulmonary Function Tests01:25

Pulmonary Function Tests

599
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
599

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaboration.

BMJ (Clinical research ed.)·2026
Same author

Real-time prediction of cardiorespiratory deterioration during paediatric critical care transport using interpretable machine learning.

PLOS digital health·2026
Same author

Function and Structure Relationships With Inflammation Differ in Two Chronic Suppurative Lung Diseases.

Pediatric pulmonology·2026
Same author

Impact of air pollution and asthma on school attendance and educational attainment: a scoping review.

BMJ open respiratory research·2025
Same author

Effects of deprescribing from inhaled corticosteroids in people with cystic fibrosis: protocol for a target trial emulation using the UK CF Registry.

BMJ open·2025
Same author

Quality standards for paediatric bronchiectasis care in the UK, a national study.

ERJ open research·2025

Related Experiment Video

Updated: Dec 8, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

356

Does newborn screening improve early lung function in cystic fibrosis?

Gwyneth Davies1

  • 1UCL Great Ormond Street Institute of Child Health, London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Paediatric Respiratory Reviews
|September 21, 2020
PubMed
Summary

Newborn screening for cystic fibrosis (CF) improves nutrition but its effect on early lung function remains unclear. More research is needed to understand the full impact of CF newborn screening on respiratory health.

Keywords:
Cystic fibrosisInfant lung functionLung clearance indexNewborn screening (NBS)Spirometry

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.5K
Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung
11:26

Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung

Published on: July 18, 2016

9.1K

Related Experiment Videos

Last Updated: Dec 8, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

356
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.5K
Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung
11:26

Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung

Published on: July 18, 2016

9.1K

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Pediatrics

Background:

  • Newborn screening (NBS) for cystic fibrosis (CF) has demonstrated benefits in nutritional outcomes.
  • The impact of NBS on early pulmonary outcomes in CF patients is less understood.
  • Evaluating NBS effects on lung function is complicated by evolving clinical practices and public health interventions.

Purpose of the Study:

  • To review methods for measuring early lung function in CF.
  • To summarize knowledge gained from CF NBS cohorts regarding pulmonary outcomes.
  • To compare pulmonary outcomes between infants diagnosed via NBS and those diagnosed symptomatically.

Main Methods:

  • Review of studies on early lung function measurement in CF NBS cohorts.
  • Analysis of comparative studies between NBS and symptomatic diagnosis groups.
  • Assessment of evidence on the impact of NBS on pulmonary outcomes.

Main Results:

  • Evidence for improved nutritional outcomes in CF NBS is established.
  • Data on the impact of NBS on early lung function is currently insufficient for firm conclusions.
  • Spirometry alone may lack sensitivity for detecting early lung disease in CF.

Conclusions:

  • There is insufficient evidence to definitively conclude the effect of NBS on early lung function in CF.
  • Future highly effective CF treatments may allow for earlier intervention, potentially revealing the full impact of NBS on lung function.
  • Further research is required to elucidate the long-term pulmonary benefits of early CF detection through NBS.